TetraLogic Pharmaceuticals (OTCMKTS:TLOG) Stock Crosses Above 50-Day Moving Average – Here’s What Happened

TetraLogic Pharmaceuticals Corporation (OTCMKTS:TLOG)’s share price crossed above its fifty day moving average during trading on Monday. The stock has a fifty day moving average of $0.00 and traded as high as $0.0001. TetraLogic Pharmaceuticals shares last traded at $0.00, with a volume of 0 shares trading hands.

TetraLogic Pharmaceuticals Stock Down 100.0%

About TetraLogic Pharmaceuticals

TetraLogic Pharmaceuticals Corporation was a clinical-stage biopharmaceutical company focused on developing small-molecule medicines for cancer and other serious diseases. Its research programs centered on therapies designed to influence programmed cell death and related cellular pathways, with the goal of selectively eliminating diseased cells.

The company’s best-known investigational product was birinapant, also known as TL32711, an antagonist of inhibitor-of-apoptosis proteins (IAPs).